1. Australia Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Telix Pharmaceuticals Limited

Telix Pharmaceuticals Limited

TLPPF
Telix Pharmaceuticals LimitedUS flagOther OTC
10.99
USD
-0.66
- -
3.72BMarket Cap

Total Valuation

Telix Pharmaceuticals Limited carries a market capitalization of 3.72B, placing it among publicly traded companies globally. Its enterprise value stands at 3.20B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.72B
Enterprise Value3.20B

Share Statistics

Telix Pharmaceuticals Limited currently has 323.73M shares outstanding.

Shares Outstanding323.73M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

PE RatioN/A
PS RatioN/A
PB Ratio31.86
P/TBV Ratio118.53
P/FCF RatioN/A
P/OCF RatioN/A

Financial Position

Telix Pharmaceuticals Limited maintains a current ratio of 1.42, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

Current Ratio1.42
Quick Ratio1.20
Debt / Equity11.95
Debt / EBITDAN/A
Interest CoverageN/A

Stock Price Statistics

Telix Pharmaceuticals Limited's stock has gained approximately 19.1974% over the past 52 weeks. The 50-day moving average sits at 10.96, while the 200-day moving average is 9.26.

Beta (5Y)N/A
52-Week Price Change19.1974%
50-Day Moving Average10.96
200-Day Moving Average9.26
Average Volume (20 Days)N/A

Balance Sheet

Telix Pharmaceuticals Limited holds 84.30M in cash and equivalents against 12.26M in total debt, resulting in a net debt position of -77.69M. Total book value stands at 102.65M, with working capital of 47.32M providing operational flexibility.

Cash & Cash Equivalents84.30M
Total Debt12.26M
Net Debt-77.69M
Equity (Book Value)102.65M
Book Value Per Share0.32
Working Capital47.32M

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-0.22
FCF YieldN/A

Scores

Telix Pharmaceuticals Limited posts an Altman Z-Score of 10.22, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score10.22